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Abstract: Mastitis, the inflammation of mammary glands, is caused by a wide range of contagious and environmental microbes, whose
clearance from the udder is generally dependent on the use of antibiotics. However, antibiotic therapy may result in development of
drug-resistant microbes and depress the activity of polymorphonuclear cells. The present study was therefore undertaken to explore
the immunotherapeutic potential of an herb, Ocimum sanctum, in mastitis in dairy cows. The study involved twenty HF × Sahiwal
lactating dairy cows, each identified with at least one specific subclinical mastitis quarter as per International Dairy Federation criteria.
The cows were divided into two equal groups: a control group and a group administered O. sanctum leaf powder at 600 mg/kg body
weight daily divided into two doses orally for 7 days. The treatment could eliminate 69.23% of intramammary infections (χ2 = 5.07; P ≤
0.5) and resulted in a significant reduction in somatic cell count and ceruloplasmin concentration, thus subsiding udder inflammation
and improving milk quality. The herb was also found to possess immunomodulation potential, as evidenced by the significant increase
in phagocytic activity of milk neutrophils and enhanced lactoperoxidase and myeloperoxidase activities. Thus, the results indicated the
immunotherapeutic potential of O. sanctum in treating bovine-specific subclinical mastitis.
Key words: Dairy cattle, mastitis, Ocimum sanctum, therapy, immunomodulation

1. Introduction
Mastitis, the inflammation of the udder, is caused by various
contagious and environmental pathogens. Excessive
and indiscriminate use of antibiotics for the clearance of
these pathogens from the udder results in emergence of
drug-resistant pathogens and also depresses the activity
of polymorphonuclear cells, the primary cellular defenses
of the udder (1). Antibiotic therapy is also disliked as it is
only moderately efficacious against established mammary
infections and requires prolonged milk withdrawal time
(2), producing hypersensitivity syndromes in humans
along with effects on the manufacturing of dairy products.
To overcome the adverse effects of antibiotic use and
enhancement of the animal’s natural defense mechanism
by use of nonspecific immunomodulators, the concept of
alternative antibiotic strategies for controlling mastitis is
gaining attention (3). Medicinal plants (herbs) constitute
a major source of alternative medicine and are used to
treat diseases of humans and animals since ancient times.
Herbal medicines have gained importance due to having
lower toxicity, fewer side effects, and no residues in the
* Correspondence: drdhirajvet@yahoo.co.in
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milk. For similar reasons, the World Health Organization
has emphasized the use of medicinal plants.
Ocimum sanctum (known as tulsi) is a valuable herbal
medicine being used in a wide spectrum of animal diseases.
It possesses immunomodulatory and antiinflammatory
properties attributed to its active constituents such as volatile
oil (eugenol, 80%), flavonoids, and triterpene, which are
largely responsible for its therapeutic potential (4). Singh et
al. (5) observed O. sanctum fixed oil, alone or in combination
with cloxacillin, a beta-lactamase-resistant penicillin, to be
beneficial in treating bovine mastitis. Mukherjee et al. (6)
reported that O. sanctum seed oil appeared to modulate both
humoral and cell-mediated immune responsiveness, and
GABAergic pathways may mediate these immunomodulatory
effects. Though some information is available on the beneficial
activities of O. sanctum in human and animal medicine, data
regarding its use as an antibacterial and immunomodulator
in bovine mastitis are scanty. Therefore, the present study was
planned to evaluate the in vivo effectiveness of O. sanctum
leaf powder in immunomodulation of the udder and therapy
of mastitis in dairy cows.
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2. Materials and methods
2.1. Design and animals allocated
Twenty HF × Sahiwal crossbred cows kept at an organized
dairy farm, found positive in at least one quarter for
specific mastitis (California Mastitis Test (CMT) score of
≥1 representing >200 × 103 somatic cells/mL and positive
for culture as per International Dairy Federation criteria),
in early to middle lactation with average weight of over 400
kg and daily milk yield of above 15–20 kg, were included
in the trial. The selected animals were divided randomly
into two groups: a control group (n = 10) administered
with placebo treatment wheat flour and a treatment group
(n = 10) administered with O. sanctum leaf powder at 600
mg/kg body weight daily (240 g total dose) divided into
two doses orally for 7 days. The dose of herb was calculated
on the following observations: 1) when administered as a
crude powder, the herb’s dose was taken as four times the
dose of herbal pure extract (7); 2) for safety reasons, the
maximum dose of a chemical should not be more than
1/10 of the 50% lethal dose (LD50) dose of that particular
chemical; 3) the LD50 dose of O. sanctum (eugenol) pure
extract was found to be 2 g/kg body weight in rats (8).
Thus, to be on the safe side, its dose was taken as 1/13 of
the LD50, i.e. 150 mg/kg body weight. Since the herb was
fed as a raw powder, it was administered at 4 times the dose
of pure extract i.e. 600 mg/kg body weight × 400 kg body
weight (240 g total dose). The calculated dose was given
separately from the animals’ daily diet and the treatment
did not show any adverse effects on the health of the cows.
2.2. Sampling and parameters studied
To assess the quarter health status, milk quality, and
immune status of the udder, sampling was done before
treatment (day 0) and at days 7, 14, and 28 after initiation
of treatment during the routine morning milking hours.
Two types of milk samples, quarter foremilk and cow
composite milk, were collected. During collection of milk
samples, proper cleanliness and dryness of the udder were
ensured. Quarter foremilk samples (about 10 mL) were
collected in sterilized test tubes, and cow composite (about
80 mL) samples were collected in clean disposable plastic
vials following cow milking. The milk samples were packed
in an ice box, transferred immediately to the laboratory,
and analyzed for various parameters as shown in Table 1.
2. 3. Analytical procedures used
2.3.1 Isolation and identification of bacteria and CMT,
pH, EC, SCC, and DLC analyses
Isolation and identification of bacteria was performed as per
the standard microbial procedures of the National Mastitis
Council (9). The CMT was conducted and interpreted as
per the method described by Pandit and Mehta (10). The
results were read as negative (-), trace, one plus (+), two plus
(++), and three plus (+++) depending upon the degree of gel

formation. The pH of milk was recorded with the help of a
digital pH meter (Systronics µpH System 361). Electrical
conductivity (EC) was recorded with the help of a digital
conductivity meter (Systronics Conductivity-TDS Meter
308) and the results were expressed in mS/cm. The milk
somatic cell count (SCC) in milk was analyzed by direct
cell counter (DeLaval) and results were expressed in ×103
cells/mL. Differential leukocyte count in milk was assessed
as per Dulin et al. (11).
2.3.2 Phagocytic activity of milk neutrophils
2.3.2.1. Preparation of milk leukocytes and adjustment
of viable cell count
The isolation of polymorphonuclear cells (PMNs) from
milk was carried out as per the method of Daley et al.
(12). In brief, 50 mL of milk was passed through cheese
cloth. The milk was then poured into 50-mL conical tubes
and centrifuged at 1200 × g or 2942 rpm for 30 min at 4
°C (Heraeus Biofuge Primo R Centrifuge). The fat was
removed and the skim milk was poured off and discarded.
The milk leukocyte pellet was washed with Hanks’
balanced salt solution (HBSS, pH 7.2) and resuspended
in HBSS with final cell concentration adjusted to 5 × 106
cells/mL. The viability of milk leukocytes was checked
by Trypan blue exclusion technique (13), involving the
mixture of 20 µL each of cell suspension and 0.1% Trypan
blue that was kept at room temperature for 2 min. A drop
of mixture was then loaded on a hemocytometer and the
viable (unstained) and dead (stained) cells were counted
in four WBC counting chambers. The viable cell count was
expressed as:
Viable cell count = Average count per square × dilution
factor × 104
The cell concentration in cell suspension was adjusted
to 1.0 × 106 cells/mL following the method of Gentle and
Thompson (14).
X (mL) of HBSS added =

No. of viable cells/mL
1.0 × 106

Thus, (X – 1) mL of HBSS was added to PMN
suspension to get a concentration of 1.0 × 106 cells/mL.
2.3.2.2. Preparation of working broth of Candida albicans
A lyophilized culture of C. albicans (ATCC 2091) was
revived on Sabouraud agar and a colony of it was inoculated
in Sabouraud broth (6 mL) followed by overnight
incubation at 37 °C. The culture suspension was then
centrifuged at 400 × g or 1699 rpm for 5–6 min to yield
a pellet that was washed twice and resuspended in HBSS
to a final concentration of 107 organisms/mL. The viability
of organisms was checked by 2 × 10–4 mol methylene blue.
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Table 1. Parameters studied in quarter foremilk and cow composite milk.
Type of milk

Sampling days

Parameters studied

QFM

0, 7, 14, and 28

Bacterial culture, California Mastitis Test (CMT), pH, electrical conductivity (EC)

CCM

0, 7, 14, and 28

Phagocytic activity, phagocytic index, somatic cell count (SCC), differential leukocyte count,
CMT, pH, EC

CCM

0, 7, and 14

Myeloperoxidase, lactoperoxidase, ceruloplasmin

QFM: Quarter foremilk, CCM: cow composite milk.

2.3.2.3. Candidacidal assay
Candidacidal assay was performed as mentioned earlier
(15). The assay involves the adding of 0.2 mL each of milk
leukocytes (106 cells), C. albicans (2 × 106 cells), and HBSS
and 0.15 mL of fresh autologous pooled bovine serum in a
test tube. This suspension was then incubated at 37 °C for
65 min with intermittent shaking, followed by the adding
of 0.25 mL of methylene blue (2 × 10–4 mol) and further
incubation for another 10 min. A drop from the final
incubation mixture was placed on the hemocytometer
to assess the phagocytic activity of milk neutrophils. The
phagocytic activity was expressed by the percentage of
phagocytosed neutrophils in 100 cells, and the phagocytic
index was determined on the basis of units of C. albicans
ingested by a single neutrophil, counted in 100 cells.
2.3.3 Myeloperoxidase (MPO), lactoperoxidase (LPx),
and ceruloplasmin activity
MPO activity in milk leukocytes was assayed according
to the method described by Bretz and Baggiolini (16). For
this substrate solution was prepared by adding citric acid
sodium citrate buffer (0.1 M, pH 5.5) in the presence of
hydrogen peroxide (0.08 M), o-dianisidine (0.32 mM),
and Triton X-100 (0.05%). The test was then initiated
by adding 0.2 mL of leukocyte suspension to 2.0 mL of
substrate solution (incubated at room temperature for 1.0
min) and the reaction was terminated by adding 2.0 mL of
35% perchloric acid. Absorbance was read at 560 nm in a
spectrophotometer (PerkinElmer Lambda 25). The molar
extinction coefficient for oxidized o-dianisidine is 20,040
± 400.
LPx in milk was measured by the method of Marshall
et al. (17). In brief, milk was diluted five times in 0.1 M
acetate buffer (pH 4.5), and from this 30 µL was rapidly
added to 2.95 mL of 1.0 mM ABTS in an acetic buffer in a
cuvette. The baseline absorbance at 412 nm was adjusted
to zero before addition of 30 µL of 10 mM hydrogen
peroxide solution in acetate buffer in a spectrophotometer
(PerkinElmer Lambda 25). The increase in extinction was
followed for 5 min and enzyme activity was expressed as
the amount of enzyme required to oxidize 1 mol ABTS/
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min. The molar extinction coefficient of ABTS is 32,400
× 103.
The estimation of ceruloplasmin level in milk was
conducted by the method of Sunderman and Nomoto (18).
The assay involves the adding of 0.1 mL of milk in both
reaction and blank tubes containing 2 mL of acetate buffer
that were then placed in a water bath (37 °C) along with a
flask containing buffered PPD. After thermal equilibrium
was achieved 1 mL of prewarmed buffered PPD solution
was added to both the tubes and they were again placed
in the water bath after proper mixing. After 5 min, 50
µL of sodium azide solution was added to the blank that
was placed in the water bath after mixing the contents
properly. After 30 min, 50 µL of sodium azide solution was
added to the reaction tube and the contents were mixed
properly. The absorbance of both tubes was read at 530
nm in a spectrophotometer (PerkinElmer Lambda 25) and
calculations were made as follows: ceruloplasmin (g/L) =
0.752 (AR – AB), where AR and AB are absorbance of the
reaction and blank, respectively.
2.3.4 Statistical analysis
All numerical data were processed via SPSS 16.0 for
Windows. Analysis of parametric data was conducted by
using ANOVA, and when the main effect was significant
then Duncan’s multiple range test was performed. The effect
of treatment on elimination of intramammary infections
was analyzed using the chi-square test. Significance level
was set at P ≤ 0.05.
3. Results
The effects of herbal therapy are detailed in Tables 2–6.
Treatment with O. sanctum leaf powder could eliminate
9/13 (69.23%) of intramammary infections as compared
to 4/15 (26.67%) in the control group at day 14 after
treatment, a significant difference (χ2 = 5.07; P < 0.05;
Table 2). Treatment showed a significant (P < 0.05) decline
in CMT scores on day 14 and day 28 of treatment in
comparison to the CMT score on day 0 (Table 3.). The
SCC of milk in the treatment group showed significant (P
< 0.05) reduction on day 28 in comparison to the SCC on
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Table 2. Elimination of intramammary infections with herbal therapy.
Intramammary infections (IMIs)
Organism

O. sanctum (T)

Control (C)
Present at day 0

Eliminated at day 14

Present at day 0

Eliminated at day 14

Staphylococci

9

3

9

6

Streptococci

1

0

2

2

Corynebacterium

5

1

2

1

Overall

15

4 (26.67)

13

9 (69.23)*

C: Control group, T: treatment group.
Values in parentheses are percentages.
Significant differences existed in elimination of IMIs between treatment and control groups. *: χ2 = 5.07; 01 df; p < 0.05.
Table 3. Effect of therapy on inflammatory reaction of udder.

Parameter

CMT score
SCC
(×103/mL)
EC (mS/cm)

pH

Group

Days after initiation of treatment
0

7

14

28

C

1.65 ± 0.171,b

1.60 ± 0.101,ab

1.50 ± 0.131,ab

1.20 ± 0.132,a

T

1.50 ± 0.151,b

1.00 ± 0.211,ab

0.80 ± 0.281,a

0.40 ± 0.231,a

C

807.80 ± 84.961,a

782.40 ± 33.721,a

771.90 ± 47.132,a

750.40 ± 44.372,a

T

762.60 ± 89.281,b

564.10 ± 95.091,ab

556.90 ± 102.361,ab

394.30 ± 83.911,a

C

6.59 ± 0.301,a

6.58 ± 0.092,a

6.41 ± 0.081,a

6.14 ± 0.122,a

T

6.42 ± 0.301,b

6.03 ± 0.2312,ab

5.87 ± 0.251,ab

5.44 ± 0.281,a

C

6.84 ± 0.031,b

6.80 ± 0.011,ab

6.79 ± 0.021,ab

6.75 ± 0.011,a

T

6.84 ± 0.031,b

6.76 ± 0.021,a

6.74 ± 0.021,a

6.72 ± 0.021,a

C: Control group, T: treatment group.
Values having at least one common superscript (letters within rows and numbers within columns) do not differ significantly at P < 0.05.
Table 4. Differential leukocyte count in control (C) and treatment groups (T).

Parameter

Neutrophils (%)

Lymphocytes (%)

Group

Days after initiation of treatment
Day 0

Day 7

Day 14

Day 28

C

51.30 ± 2.791,a

53.60 ± 2.871,a

51.30 ± 3.002,a

44.50 ± 3.092,a

T

50.30 ± 2.571,c

55.70 ± 2.541,c

38.40 ± 2.351,b

24.10 ± 2.721,a

C

15.20 ± 0.421,a

15.30 ± 0.301,a

16.20 ± 0.661,ab

17.30 ± 0.701,b

T

16.20 ± 0.611,a

15.40 ± 0.851,a

16.80 ± 0.531,ab

18.30 ± 0.721,b

Values having at least one common superscript (letters within rows and numbers within columns) do not differ significantly at P < 0.05.
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Table 5. Phagocytic activity and phagocytic index in control (C) and treatment groups (T).
Days after initiation of treatment

Parameters

Group

Phagocytic
activity (%)

C

15.30 ± 0.70

T

Phagocytic
index

Day 0

Day 7

Day 14

Day 28

16.30 ± 0.47

1,a

16.50 ± 0.67

16.80 ± 0.661,a

17.10 ± 0.641,a

29.10 ± 1.622,c

28.80 ± 1.202,c

24.00 ± 1.342,b

C

1.07 ± 0.021,a

1.09 ± 0.031,a

1.10 ± 0.031,a

1.10 ± 0.031,a

T

1.10 ± 0.031,a

1.58 ± 0.092,c

1.22 ± 0.042,ab

1.31 ± 0.072,b

1,a

1,a

Values having at least one common superscript (letters within rows and numbers within columns) do not differ significantly at P < 0.05.
Table 6. Myeloperoxidase (MPO), lactoperoxidase (LPx), and ceruloplasmin levels in control (C) and treatment groups (T).

Parameters

Group

Days after initiation of treatment
Day 0

Day 7

Day 14

C

437.325 ± 16.751,a

423.15 ± 9.951,a

412.28 ± 7.092,a

T

452.910 ± 11.891,b

717.4 ± 50.062,c

228.91 ± 25.531,a

C

0.300 ± 0.011,a

0.293 ± 0.011,a

0.287 ± 0.012,a

T

0.294 ± 0.011,b

0.378 ± 0.002,c

0.173 ± 0.001,a

Ceruloplasmin

C

0.139 ± 0.011,a

0.137 ± 0.012,a

0.135 ± 0.012,a

(g/L)

T

0.137 ± 0.011,b

0.061 ± 0.011,a

0.065 ± 0.011,a

MPO (µmol/min)
LPx (µmol/min)

Values having at least one common superscript (letters within rows and numbers within columns) do not differ significantly at P < 0.05.

day 0, as presented in Table 3. A similar trend was also
observed with pH and EC values in the treatment group.
The ceruloplasmin concentration in the treatment group
decreased significantly (P < 0.05) to 0.061 ± 0.01 on day
7 from 0.137 ± 0.01 on day 0 (Table 6). During the course
of investigation, i.e. day 0 to day 28, the mean neutrophil
percentage remained high, although it decreased from
51.30 ± 2.79% to 44.50 ± 3.09% and the lymphocyte
percentage increased from 15.20 ± 0.42% to 17.30 ± 0.70%
in the control group, indicating the presence of some
subclinical mastitis in the herd (Table 4).
In O. sanctum-treated cows, a significant (P < 0.05)
increase was observed in phagocytic activity (Figure) at
day 7 of treatment, and it remained significantly elevated
throughout the course of the study as compared to day 0,
although it showed some decreasing trends from day 14
to day 28 of treatment (Table 5).The phagocytic index was
seen to be decreased at day 14 and day 28 as compared to
day 7, but still it was a significant change as compared to
day 0.
The MPO and LPx activities were significantly (P
< 0.05) augmented in the treatment group at day 7 and
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decreased significantly (P < 0.05) at day 14 as compared to
day 0 (Table 6).
4. Discussion
Mastitis is one of the most costly diseases resulting in
huge global economic losses, including in India. The use
of antibiotics as the mainstay of treating this problem
instigates public health hazards due to the persistence of
antibiotic residues in the milk and development of drugresistant bacterial pathogens. To lessen the adverse effects
of antibiotics, a different approach of preventing mastitis,
i.e. O. sanctum administration, was evaluated in vivo for
its therapeutic potential in specific subclinical mastitis of
dairy cows.
The differences in elimination of intramammary
infections in the treatment vs. the control group were
observed to be statistically significant (P < 0.05) with a
chi-square value of 5.07 (Table 2). Several studies have
evaluated different herbs and indicated beneficial effects of
herbal remedies against bovine mastitis (19,20). Baskaran
et al. (21) evaluated the antimicrobial effect of plantderived antimicrobials, including carvacrol, eugenol,
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Figure. Phagocytosis of C. albicans (arrow) by PMN cell. Under oil immersion, 100×
magnification, staining with methylene blue.

thymol, and trans-cinnamaldehyde, and concluded that all
4 ingredients exhibited antimicrobial activity against the 5
mastitis pathogens tested. However, due to the differences
in active compounds of different herbs, the efficacies may
differ.
There was a significant reduction in SCC, CMT score,
and acute phase protein (ceruloplasmin), suggesting
the antiinflammatory action of the herb. Mastitis results
in increased somatic cells, which are reflective of udder
inflammation, and there is also an increase in acute phase
protein due to the high permeability of the blood–milk
barrier due to inflammatory changes in the udder (22). The
significant decline in CMT, SCC, pH, and EC in the present
study are in agreement with Gupta (23), who administered
oral herbal powder mix containing O. sanctum to animals
affected with subclinical mastitis. Mukherjee et al. (6) also
reported that intramammary use of aqueous extract of O.
sanctum leaves in bovine subclinical mastitis resulted in
significant decreases in CMT and SCC.
Neutrophils, the first line of defense against invading
pathogens, are recruited earliest among other leukocytes
to the site of infection and are also important host defense
mechanisms in mastitis by virtue of their phagocytosis and
intracellular killing (24). Any imbalance in their effective
functioning can result in the flourishing of pathogens in
the udder, resulting in mastitis. This imbalance can be kept
in check by enhancing phagocytic potential and migration
of PMNs from the circulation to an inflamed udder that
helps in removal of infective agents from the udder. In
the present study, the significant increases in phagocytic
activity/phagocytic index and subsequent elimination

of intramammary infection suggest that the herb has
immunomodulatory action, a finding in agreement with
Rastogi et al. (25).
MPO,
a
constituent
of
oxygen-dependent
antimicrobial activity of leukocytes, and LPx, a component
of the lactoperoxidase system along with thiocyanate
and hydrogen peroxide, serve as effective antimicrobial
weapons against many infective pathogens. Their activity
is expected to increase with an increase in SCC in milk
and is directly correlated with the level of the SCC (26).
The activity of both MPO and LPx was significantly
increased in the present study, suggesting the positive
effect of O. sanctum on the activity of leukocytes, which
is also supported by the results of significant elimination
of infection and decrease in SCC. Our findings are in
conformity with the findings of Rastogi et al. (25), who
observed that aqueous extract of O. sanctum in the case
of mastitis enhanced the lysosomal enzyme contents of
the milk PMNs. The results of enhanced phagocytosis,
LPx, and MPO activities could be attributed to antioxidant
properties, enhanced milk leukocyte activity (i.e. hydrogen
peroxide production), and increased activity of the
lysosomal enzymes conferred by the immunomodulatory
properties of O. sanctum.
In conclusion, the data obtained from the present
study indicate beneficial effects of herbal therapy against
subclinical mastitis in lactating dairy cows. The positive
effects of these remedies may be related to the presence
of lipophilic constituents in herbs that have antibacterial,
antiinflammatory, and immunomodulation potential as
substantiated by elimination of intramammary infections,
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decrease of milk SCC and ceruloplasmin activity, and
enhanced phagocytosis, LPx, and MPO activities of milk
leukocytes in the present study.
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